SCHEMBL7665180

SCHEMBL7665180

CC(C)(C)OC(=O)CNS(=O)(=O)c1ccc(NC(=O)c2ccccc2F)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
TDP1 Q9NUW8 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
HSD17B10 Q99714 1/20 0.50
POLB P06746 2/20 0.49
KAT6A Q92794 1/20 0.49
LMNA P02545 3/20 0.49
MAPT P10636 4/20 0.48
TP53 P04637 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
HTT P42858 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671600 0.88 ALDH1A1 (0.51) KDM4EMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL7670478 0.87 TP53 (0.56) KMT2ASMN1; SMN2HSD17B10POLBLMNA
SCHEMBL7669835 0.86 RXFP1 (0.61) MEN1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL7669734 0.85 MEN1 (0.52) KDM4EMEN1KMT2ANPC1RAB9A
SCHEMBL7669548 0.84 ALDH1A1 (0.64) MEN1KMT2ASMN1; SMN2RAB9AHSD17B10
SCHEMBL7582747 0.84 LMNA (0.65) MEN1KMT2ASMN1; SMN2POLBLMNA
SCHEMBL7674309 0.83 MEN1 (0.61) KDM4EMEN1KMT2ATDP1SMN1; SMN2
SCHEMBL7667906 0.82 KMT2A (0.56) MEN1KMT2ATDP1SMN1; SMN2NPC1
SCHEMBL7663740 0.82 ALDH1A1 (0.65) MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7675460 0.82 SGMS2 (0.58) MEN1KMT2AHSD17B10LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed